BGC > Produktsuche > Abiraterone acetate

Molecular Formula: C26H33NO2
Molecular Weight: 391.55

Specification	CP/USP
Documentation	DMF under Filing

Description:
The acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. It can be used to treat metastatic, castration-resistant prostate cancer.

• Molecular Weight:391.55
• Melting Point:127-130 °C
• Purity:>98%

Molecular Formula:
C26H33NO2
Canonical SMILES:
CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
InChI:
InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1
InChIKey:
UVIQSJCZCSLXRZ-UBUQANBQSA-N
Appearance:
Off-white solid
Application:
the treatment of metastatic, castration-resistant prostate cancer
Synonyms:
CB7630; Zytiga; CB-7630; CB7630; Abiraterone (acetate)